KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $10.9 million.

  • Biolife Solutions' Accumulated Expenses rose 2906.85% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 2906.85%. This contributed to the annual value of $12.5 million for FY2024, which is 3650.92% up from last year.
  • Per Biolife Solutions' latest filing, its Accumulated Expenses stood at $10.9 million for Q3 2025, which was up 2906.85% from $9.3 million recorded in Q2 2025.
  • Biolife Solutions' Accumulated Expenses' 5-year high stood at $12.5 million during Q4 2024, with a 5-year trough of $6.7 million in Q1 2022.
  • For the 5-year period, Biolife Solutions' Accumulated Expenses averaged around $9.2 million, with its median value being $9.1 million (2023).
  • In the last 5 years, Biolife Solutions' Accumulated Expenses surged by 28031.47% in 2021 and then crashed by 3830.97% in 2022.
  • Quarter analysis of 5 years shows Biolife Solutions' Accumulated Expenses stood at $9.4 million in 2021, then increased by 4.09% to $9.8 million in 2022, then decreased by 6.76% to $9.1 million in 2023, then soared by 36.51% to $12.5 million in 2024, then decreased by 12.42% to $10.9 million in 2025.
  • Its Accumulated Expenses stands at $10.9 million for Q3 2025, versus $9.3 million for Q2 2025 and $8.2 million for Q1 2025.